Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Molecular Profiling for Proper Diagnosis of Gastroenteropancreatic Neuroendocrine Tumor.

Literature DB >> 32923901

Molecular Profiling for Proper Diagnosis of Gastroenteropancreatic Neuroendocrine Tumor.

Virian D Serei¹, Elizabeth Poplin¹, Shridar Ganesan¹, Gregory Riedlinger¹.

Abstract

Entities: Disease

Year: 2020 PMID： 32923901 PMCID： PMC7446509 DOI： 10.1200/PO.20.00111

Source DB: PubMed Journal: JCO Precis Oncol ISSN： 2473-4284

× No keyword cloud information.

19 in total

1. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.

Authors: Laura H Tang; Brian R Untch; Diane L Reidy; Eileen O'Reilly; Deepti Dhall; Lily Jih; Olca Basturk; Peter J Allen; David S Klimstra
Journal: Clin Cancer Res Date: 2015-10-19 Impact factor: 12.531

Review 2. Somatic and germline mutations in NETs: Implications for their diagnosis and management.

Authors: Marianna Minnetti; Ashley Grossman
Journal: Best Pract Res Clin Endocrinol Metab Date: 2015-10-09 Impact factor: 4.690

3. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging.

Authors: Mahul B Amin; Frederick L Greene; Stephen B Edge; Carolyn C Compton; Jeffrey E Gershenwald; Robert K Brookland; Laura Meyer; Donna M Gress; David R Byrd; David P Winchester
Journal: CA Cancer J Clin Date: 2017-01-17 Impact factor: 508.702

Review 4. Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.

Authors: Siaw M Chai; Ian S Brown; M Priyanthi Kumarasinghe
Journal: Histopathology Date: 2018-01 Impact factor: 5.087

5. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.

Authors: Yuchen Jiao; Chanjuan Shi; Barish H Edil; Roeland F de Wilde; David S Klimstra; Anirban Maitra; Richard D Schulick; Laura H Tang; Christopher L Wolfgang; Michael A Choti; Victor E Velculescu; Luis A Diaz; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Nickolas Papadopoulos
Journal: Science Date: 2011-01-20 Impact factor: 47.728

6. Hodgkin Lymphoma and Cutaneous T-Cell Lymphoma Sharing the PCM1-JAK2 Fusion and a Common T-Cell Clone.

Authors: Gregory M Riedlinger; Aleksander Chojecki; Hana Aviv; David Weissmann; Sonali Joshi; Susan M Murphy; Kim M Hirshfield; Shridar Ganesan
Journal: JCO Precis Oncol Date: 2019-06-19

Review 7. Molecular pathogenesis and targeted therapy of sporadic pancreatic neuroendocrine tumors.

Authors: Gabriele Capurso; Livia Archibugi; Gianfranco Delle Fave
Journal: J Hepatobiliary Pancreat Sci Date: 2015-01-25 Impact factor: 7.027

8. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.

Authors: Laura H Tang; Olca Basturk; Jillian J Sue; David S Klimstra
Journal: Am J Surg Pathol Date: 2016-09 Impact factor: 6.394